Indogulf Cropsciences Limited (IN:IGCL)
:IGCL
Want to see IN:IGCL full AI Analyst Report?
Top Page
Indogulf Cropsciences Limited
(IGCL)
Select Model
Select Model
Rating:53Neutral
Price Target:
₹59.00
▼(-7.71% Downside)
Action:N/A
Date:05/31/26
The score is held back primarily by weak cash generation (negative operating and free cash flow in both FY2025 and FY2026) and bearish technicals (below major moving averages with negative MACD). These are partially offset by strong reported FY2026 revenue growth, improved leverage, and a low P/E valuation.
Positive Factors
Strong Revenue and Profitability
A >100% reported revenue increase alongside positive gross and net margins indicates meaningful market traction for core crop-protection products. Sustained top-line expansion can enable scale benefits, reinvestment in distribution and R&D, and a more durable earnings base if operational execution remains consistent.
Negative Factors
Weak Cash Generation
Consecutive years of negative operating and free cash flow indicate earnings are not converting to cash, pointing to working-capital strain or cash burn. Persistent cash deficits raise dependence on external financing, constrain capex and inventory management, and pose a multi-quarter risk to sustainable operations.
Read all positive and negative factors
Positive Factors
Negative Factors
Strong Revenue and Profitability
A >100% reported revenue increase alongside positive gross and net margins indicates meaningful market traction for core crop-protection products. Sustained top-line expansion can enable scale benefits, reinvestment in distribution and R&D, and a more durable earnings base if operational execution remains consistent.
Read all positive factors
Indogulf Cropsciences Limited (IGCL) vs. iShares MSCI India ETF (INDA)
Market Cap
₹3.95B
Dividend YieldN/A
Average Volume (3M)12.83K
Price to Earnings (P/E)8.2
Beta (1Y)1.13
Revenue GrowthN/A
EPS GrowthN/A
CountryIN
Employees657
SectorBasic Materials
Sector Strength58
IndustryAgricultural Inputs
Share Statistics
EPS (TTM)3.85
Shares Outstanding63,223,995
10 Day Avg. Volume12,856
30 Day Avg. Volume12,826
Financial Highlights & Ratios
PEG Ratio2.10
Price to Book (P/B)0.77
Price to Sales (P/S)0.50
P/FCF Ratio-4.19
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Indogulf Cropsciences Limited Business Overview & Revenue Model
Company Description
Indogulf Cropsciences Limited is engaged in the production and distribution of a wide array of agricultural solutions, encompassing crop protection agents, plant nourishment products, and biological inputs. These are supplied to both individual co...
How the Company Makes Money
IGCL primarily makes money by selling crop protection products. Key revenue streams typically include: (1) sales of formulated crop protection products (e.g., insecticides, fungicides, herbicides) sold through distributors/retail channels to end c...
Indogulf Cropsciences Limited Financial Statement Overview
Summary
Income Statement
72
Positive
Balance Sheet
68
Positive
Cash Flow
24
Negative
| Breakdown | TTM | Jun 2025 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 3.48B | 7.05B | 5.90B | 5.51B | 5.49B | 4.86B |
| Gross Profit | 1.07B | 1.50B | 1.04B | 1.54B | 1.39B | 1.25B |
| EBITDA | 443.02M | 815.88M | 696.86M | 587.04M | 508.71M | 495.97M |
| Net Income | 243.44M | 400.27M | 314.72M | 282.33M | 224.23M | 263.63M |
Balance Sheet | ||||||
| Total Assets | 8.66B | 8.27B | 6.90B | 5.42B | 5.18B | 4.14B |
| Cash, Cash Equivalents and Short-Term Investments | 288.71M | 123.12M | 96.85M | 5.65M | 1.98M | 11.87M |
| Total Debt | 2.08B | 1.83B | 2.31B | 1.59B | 1.95B | 1.07B |
| Total Liabilities | 4.26B | 3.67B | 4.15B | 3.11B | 3.14B | 2.33B |
| Stockholders Equity | 4.40B | 4.59B | 2.75B | 2.32B | 2.03B | 1.81B |
Cash Flow | ||||||
| Free Cash Flow | -1.02B | -838.86M | -704.15M | 284.92M | -771.71M | -202.11M |
| Operating Cash Flow | -767.21M | -554.64M | -282.36M | 533.40M | -570.10M | -70.05M |
| Investing Cash Flow | -392.78M | -386.91M | -403.49M | -52.25M | -192.94M | -100.15M |
| Financing Cash Flow | 1.20B | 967.82M | 753.54M | -488.85M | 751.98M | 160.94M |
Indogulf Cropsciences Limited Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
66 Neutral | ₹3.86B | 7.47 | ― | ― | 7.26% | -6.47% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
56 Neutral | ₹4.47B | 8.47 | ― | 0.46% | 20.08% | 180.73% | |
53 Neutral | ₹3.95B | 8.17 | ― | ― | ― | ― | |
43 Neutral | ₹467.09M | -1.06 | ― | ― | -26.89% | -760.69% | |
38 Underperform | ₹2.14B | -7.28 | ― | ― | -100.00% | -101.24% |
* Basic Materials Sector Average
IN:IGCL
Indogulf Cropsciences Limited
64.41
-43.24
-40.17%
IN:MANAKSIA
Manaksia Limited
59.75
-14.71
-19.76%
IN:MANGALAM
Mangalam Drugs & Organics Ltd.
30.18
-50.95
-62.80%
IN:NAGAFERT
Nagarjuna Fertilizers & Chemicals Ltd.
3.58
-2.24
-38.49%
IN:RAMAPHO
Rama Phosphates Limited
126.65
8.79
7.46%
Indogulf Cropsciences Limited Corporate Events
Indogulf Cropsciences Publishes Q4 FY26 Results Call Audio for Investors
May 29, 2026
Indogulf Cropsciences Limited informed stock exchanges that it held a conference call with analysts and investors on May 29, 2026 to discuss its audited standalone and consolidated financial results for the fourth quarter of FY 2025-26. The compan...
Indogulf Cropsciences clears FY26 results and bolsters audit framework
May 28, 2026
Indogulf Cropsciences Limited’s board has approved the audited standalone and consolidated financial results for the quarter and financial year ended 31 March 2026, with auditors issuing an unmodified opinion, underscoring the integrity of t...
Indogulf Cropsciences Posts Robust FY26 Growth on Distribution and Export Gains
May 28, 2026
Indogulf Cropsciences reported a strong FY26 performance, with consolidated revenue from operations rising 19% year-on-year to ₹7,046 million and profit after tax climbing 27% to ₹400 million, even as EBITDA margin softened slightly. T...
Indogulf Cropsciences Releases Q4 and FY26 Earnings Call Presentation
May 28, 2026
Indogulf Cropsciences Limited has released its investor earnings call presentation covering the audited financial results for the fourth quarter and full financial year ended March 31, 2026. The materials, aligned with Indian listing regulations, ...
Indogulf Cropsciences files IPO proceeds monitoring and deviation reports for FY 2026
May 12, 2026
Indogulf Cropsciences Limited has submitted a Monitoring Agency Report from Brickwork Ratings India Private Limited and a Statement of Deviation or Variation for the quarter and year ended March 31, 2026. These documents detail the monitoring and ...
Indogulf Cropsciences Secures Shareholder Nod for Postal Ballot Resolutions
Mar 31, 2026
Indogulf Cropsciences Limited has reported that shareholders have approved all resolutions presented through a recent postal ballot conducted via remote e-voting. The scrutinizer, an independent practicing company secretary, confirmed that the ite...
Indogulf Cropsciences Closes Trading Window Ahead of FY26 Results
Mar 25, 2026
Indogulf Cropsciences Limited has announced that its trading window for dealings in the company’s shares and securities will be closed from 1 April 2026, in line with SEBI (Prohibition of Insider Trading) Regulations, 2015 and its internal c...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.